Additional file 1: of The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells

Table S1. Sensitivity of TNBC cells to PI3K/mTOR inhibitors. HCC38 cells and MDA-MB-231 cells were treated with increasing concentrations of the indicated PI3K/mTOR inhibitors. After 72h cell proliferation was evaluated by CV staining. Data are expressed as EC50 values and are means ÂąSD of three independent expreiments (n = 5). (TIFF 371 kb